View the NewsRx Library

Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Google 2009 PageRank: #2 Among Top Health News and Media Publications

Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This site complies with the HONcode standard for trustworthy health information:
verify here.

Clinical Trials Week

Susan Hasty, Publisher
Table of Contents . . . March 23rd, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

Alexza Pharmaceuticals, Inc. - Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status

Psoriasis - BioCis Pharma Starts Phase IIa Trial in Psoriasis

Schering-Plough Corporation - Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study

Breast Cancer - Research from D. Generali et al has provided new information about breast cancer

Cancer - Recent findings in cancer described by researchers from University of California

Cancer - Research data from J.L. Lefebvre and colleagues update understanding of cancer

Cancer Vaccines - New cancer vaccines research reported from Leiden University

Chronic Myeloid Leukemia - Reports outline chronic myeloid leukemia study findings from St. Orsola-Malpighi University

Colon Cancer - Scientists at University of California publish research in colon cancer

Glioblastoma - New glioblastoma findings from Duke University published

Glioblastoma - Researchers at National Institutes of Health release new data on glioblastoma

Head and Neck Cancer - Data from M. Supriya et al provide new insights into head and neck cancer

HIV/AIDS Cancer - Study results from Brigham and Women's Hospital update understanding of HIV/AIDS cancer

Life Sciences - Investigators at St. Louis University target life sciences

Monoclonal Antibodies - New monoclonal antibodies study findings recently were reported by O. Stuve and co-researchers

Myeloma - New myeloma data have been reported by J.R. Berenson and co-authors

Pneumonia - New pneumonia research from Emory University discussed

Pneumonia - Studies in the area of pneumonia reported from C.H. Jones and co-researchers

Secondary Hyperparathyroidism - Research on secondary hyperparathyroidism detailed by scientists at University of Colorado

Thrombocytopenic Purpura - Research in the area of thrombocytopenic purpura reported from McMaster University

Clinical Trial Research - Research on clinical trial research discussed by scientists at Lancaster University

Clinical Trial Research - Studies from University of Turin add new findings in the area of clinical trial research

Digestive System Neoplasms Cell Biology - Research findings from University of Texas update understanding of digestive system neoplasms cell biology

Glioblastoma Therapy - Researchers from University Hospital detail new studies and findings in the area of glioblastoma therapy

Lymphoma Clinical Trial - Studies from Ohio State University, Division of Hematology-Oncology provide new data on lymphoma clinical trial

Myeloma Therapy - Research data from University of Washington, Fred Hutchinson Cancer Research Center update understanding of myeloma therapy

Myeloma Therapy - Researchers from St. Bartholomew's Hospital, Department of Haematology detail findings in myeloma therapy

Ovarian Cancer Therapy - Research Institute and Hospital details research in ovarian cancer therapy

Solid Cancer Immunology - Researchers from Chinese Academy of Medical Sciences, Department of Medical Oncology describe findings in solid cancer immunology

Acne Vulgaris - AndroScience Corporation Announces Phase 2a Study Results on ASC-J9(TM) for the Treatment of Acne

Acute Myeloid Leukemia - Celator(R) Pharmaceuticals Enrolls First Patient in Its Phase 2 Study of CPX-351 in Acute Myeloid Leukemia in First Relapse

Advanced Cell Technology, Inc. - Advanced Cell Technology Secures $5 Million Credit Facility to Develop RPE Program for the Treatment of Diseases of the Eye

Affymax, Inc. - Affymax® Reports Year End 2008 Financial Results

Afibrinogenemia - CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency

Anacor Pharmaceuticals - Anacor Announces Positive Results from Phase 1 Safety Trial of AN2898 for Psoriasis and Atopic Dermatitis

Antares Pharma, Inc. - Antares Pharma to Host Fourth Quarter and Year-End 2008 Earnings Call

Antares Pharma, Inc. - Antares to Present at Cowen and Company 29th Annual Health Care Conference

AVEO Pharmaceuticals, Inc. - AVEO Initiates Phase 1b/2a Clinical Trial of Novel, Triple VEGF Receptor Inhibitor AV-951 in Non-Small Cell Lung Cancer

Biologics - Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration

Bronchitis - BioMarck Pharmaceuticals Announces the Allowance of Two US Patents on Lead COPD Therapeutic

Cancer - New Hope to Beat Cancer

Cancer Vaccines - CEL-SCI Announces Exclusive Licensing Agreement for Cancer Drug Multikine(R) for Republic of South Africa

Clinical Trial Research - AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results

Clinical Trial Research - Johnson & Johnson to Provide Webcast Presentation of Tapentadol Extended Release (ER) Phase 3 Clinical Data Presented at World Institute of Pain 5th Annual World Congress

Clinical Trial Research - QLT announces completion of Phase Ia safety trial of its synthetic retinoid product

Covance Inc. - Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site

Diabetes - Spherix Postpones 2009 Annual Shareholders Meeting to Share Interim Diabetes Clinical Trial Data

DOR BioPharma, Inc. - DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer

Drug Resistance - NovaBay Pharmaceuticals Announces Lead Anti-infective Product Candidate, NVC-422, Shown to be Effective in Treating Topical Fungal Infection

Dynavax Technologies Corporation - Dynavax Announces Extension of AstraZeneca Research Collaboration

Fate Therapeutics, Inc. - Fate Therapeutics Further Expands Executive Management Team to Advance Discovery and Development of Stem Cell Therapeutics

Genta Incorporated - FDA Appeal Decision Indicates that Genasense® Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Trial

Inhibitex, Inc. - Inhibitex Reports Fourth Quarter and Calendar Year 2008 Financial Results and Highlights

Jina Ventures - Jina Ventures Advises Swiss Pharma Contract on Strategic Sale to Covance Inc

Knopp Neurosciences Inc. - European Commission Awards Orphan Designation to Knopp Neurosciences’ KNS-760704 in ALS

Nanotherapeutics, Inc. - Nanotherapeutics Advances Two Clinical Programs

Non-Small Cell Lung Cancer - Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours

Obesity and Diabetes - InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study

Oncothyreon Inc. - Oncothyreon reports full year and fourth quarter 2008 financial results

Optimer Pharmaceuticals, Inc. - Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Financial Results

Pfizer Inc - Sutent Significantly Increases Progression Free Survival for Patients with Advanced Pancreatic Islet Cell Tumors, Study Stopped Early

Pharmaceuticals - Intra-Cellular Therapies Reports Positive Final Results of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia

Pharmaceuticals - Quark Pharmaceuticals Presents at Asia TIDES Conference

Protalix BioTherapeutics, Inc. - Protalix BioTherapeutics Receives Research Grant of over $6 Million from the Israeli Government’s Office of the Chief Scientist

Regeneron Pharmaceuticals, Inc. - Regeneron Announces Presentation at the Barclays Capital Global Healthcare Conference

Regeneron Pharmaceuticals, Inc. - Regeneron Announces Presentation at the Cowen and Company 29th Annual Healthcare Conference

Rigel Pharmaceuticals, Inc. - Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas

Solasia Pharma K.K. - Clinical Development of Solasia’s First Drug Initiated in Japan – Clinical Trials Also Planned for China

Synta Pharmaceuticals Corp. - Synta Restructures Organization to Focus on New Priorities

Takeda Pharmaceuticals North America, Inc. - ULORIC febuxostat 40-mg and 80-mg Tablets Now Available for the Chronic Management of Hyperuricemia in Patients with Gout

Type 1 Diabetes - Tolerx Expands Phase 3 'DEFEND' Trial of Otelixizumab in Europe

VIVUS, Inc. - VIVUS Reports 2008 Fourth Quarter and Full-Year Financial Results

Return to Top of Page


Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search \| Visit VerticalNews.com Copyright © 2009 NewsRx